The efficacy and safety of fingolimod plus standardized treatment versus standardized treatment alone for acute ischemic stroke: A systematic review and meta‐analysis

• Main Authors: Peng Bai (Author), Runxiu Zhu (Author), Ping Wang (Author), Feng Jiang (Author), Jin Zhen (Author), Yuan Yao (Author), Chenhui Zhao (Author), Zihong Liang (Author), Meiling Wang (Author), Bin Liu (Author), Min Li (Author), Na Li (Author), Jun Yuan (Author)
• Format: Book
• Published: Wiley, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Acute ischemic stroke (AIS) is the most common type of stroke. Fingolimod is a sphingosine analog that acts on sphingosine‐1‐phosphate receptors (S1PR). Recently, the safety and efficacy of fingolimod in both patients with intracerebral hemorrhage and patients with AIS have been investigate...